JPMORGAN CHASE & CO - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$241,208,570
-10.2%
8,887,567
+1.7%
0.03%
-6.9%
Q2 2023$268,549,912
-14.0%
8,736,171
+0.7%
0.03%
-23.7%
Q1 2023$312,436,000
+93739.6%
8,671,563
+2.9%
0.04%
-13.6%
Q4 2022$332,947
-99.9%
8,424,747
+1.1%
0.04%
-8.3%
Q3 2022$334,764,000
+4.1%
8,331,597
+8.9%
0.05%
+6.7%
Q2 2022$321,522,000
+48.4%
7,647,985
+37.6%
0.04%
+73.1%
Q1 2022$216,592,000
+0.2%
5,559,388
+2.5%
0.03%
+4.0%
Q4 2021$216,075,000
+12.5%
5,422,203
+2.0%
0.02%
+4.2%
Q3 2021$192,138,000
-35.9%
5,316,482
-27.3%
0.02%
-33.3%
Q2 2021$299,842,000
+18.6%
7,315,001
+26.2%
0.04%
+5.9%
Q1 2021$252,790,000
-16.9%
5,795,267
-4.7%
0.03%
-24.4%
Q4 2020$304,322,000
+93.1%
6,080,359
+62.1%
0.04%
+73.1%
Q3 2020$157,590,000
-12.8%
3,751,236
+0.7%
0.03%
-25.7%
Q2 2020$180,797,0003,723,9240.04%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2020
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders